- Home
- SUPN vs APLD Comparison
SUPN vs APLD Comparison
Compare SUPN & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | APLD |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 9.3B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | SUPN | APLD |
|---|---|---|
| Price | $51.47 | $24.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $61.60 | $29.36 |
| AVG Volume (30 Days) | 636.6K | ★ 24.8M |
| Earning Date | 11-04-2025 | 01-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $681,539,000.00 | $173,560,000.00 |
| Revenue This Year | $8.32 | $113.90 |
| Revenue Next Year | $23.36 | $71.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.54 | ★ 28.43 |
| 52 Week Low | $29.16 | $3.31 |
| 52 Week High | $57.65 | $40.20 |
Technical Indicators
Market Signals| Indicator | SUPN | APLD |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 44.18 |
| Support Level | $51.01 | $22.15 |
| Resistance Level | $52.30 | $29.46 |
| Average True Range (ATR) | 1.42 | 2.41 |
| MACD | 0.55 | -0.27 |
| Stochastic Oscillator | 86.60 | 19.23 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.